Our award-winning logical data management platform is regularly featured in the world's leading business and IT publications worldwide.
Have a question?
Have a question?
(+1) 650 566 8833
Our award-winning logical data management platform is regularly featured in the world's leading business and IT publications worldwide.
Denodo, a leader in data management, announced that it has been placed as a top vendor in the 2025 Active Data Architecture™ report from Dresner Advisory Services. Dresner defines an “Active Data Architecture™” as that which “supports a platform-independent layer that sits between physical data stores and points of data consumption,” to overcome the challenges that many organizations have in maintaining the flexibility, adaptability, and scalability of their data infrastructures.
Denodo, a global leader in data management, has once again been named the top vendor in the 2025 Active Data Architecture™ report by Dresner Advisory Services, marking its second consecutive year in the top position. The recognition highlights Denodo’s strength in data integration, metadata management, data governance, performance, and its commitment to advancing Active Data Architecture (ADA) principles for modern enterprises.
Denodo has entered into a Memorandum of Understanding with ST Engineering Mission Software Systems to jointly progress data science and artificial intelligence technologies.
Principal Financial Group, a Fortune 500 global financial services leader with over $700 billion in assets under management, has long been recognized for its commitment to helping customers plan, protect, and invest for a secure financial future. As the organization deepens its focus on digital transformation, it’s betting on data and AI to power that future responsibly and at scale.
What if business intelligence didn't stop at answering what happened, but could finally explain why? In this episode of Tech Talks Daily, I sit back down with Alberto Pan, Chief Technology Officer at Denodo, to unpack how Deep Query is redefining enterprise AI through reasoning, transparency, and context.
Denodo has partnered with ST Engineering Mission Software Systems to jointly advance data science and artificial intelligence (DSAI) technologies. Under the partnership, both companies will collaborate on knowledge sharing, technical development and joint delivery of data-driven services for customers in the government and commercial sectors.
Providing fast and intuitive access to information has long been high on the agenda – not least for data professionals. Over the past decades, we have collected and produced enormous amounts of data, more than we have really known what to do with.
Denodo, a global data management firm, has signed a strategic Memorandum of Understanding (MOU) with ST Engineering Mission Software Systems, a Singapore-based company of global technology, defence and engineering group ST Engineering, to jointly advance data science and artificial intelligence (DSAI) technologies.
Denodo has signed a strategic Memorandum of Understanding (MOU) with ST Engineering Mission Software Systems to advance the development of data science and artificial intelligence (DSAI) technologies. The agreement marks a new step towards enhancing AI-enabled sensemaking capabilities for government and commercial sectors.
Download the Denodo Platform to explore, learn, and build with governed data access.
DOWNLOAD FOR FREEExperience the full Denodo Platform with Agora, our fully managed cloud service.
START FREE TRIAL
Better together: Why primary care wins when physicians, payers and pharma share data
If you’re a primary care physician in the United States, you likely spend too much time navigating administrative complexity and too little time delivering care. Between prior authorizations, fragmented records and incomplete medication histories, your clinical decisions are often made without the whole picture. But what if that picture could be filled in, not just by hospitals or electronic health records (EHRs), but by the very stakeholders that sit on the other side of the care equation: insurers and life sciences organizations?